Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review

Radiomics or textural feature extraction obtained from positron emission tomography (PET) images through complex mathematical models of the spatial relationship between multiple image voxels is currently emerging as a new tool for assessing intra-tumoral heterogeneity in medical imaging. In this paper, available literature on texture analysis using FDG PET imaging in patients suffering from tumors of the gastro-intestinal tract is reviewed. While texture analysis of FDG PET images appears clinically promising, due to the lack of technical specifications, a large variability in the implemented methodology used for texture analysis and lack of statistical robustness, at present, no firm conclusions can be drawn regarding the predictive or prognostic value of FDG PET texture analysis derived indices in patients suffering from gastro-enterologic tumors. In order to move forward in this field, a harmonized image acquisition and processing protocol as well as a harmonized protocol for texture analysis of tumor volumes, allowing multi-center studies excluding statistical biases should be considered. Furthermore, the complementary and additional value of CT-imaging, as part of the PET/CT imaging technique, warrants exploration.

[1]  Frank J. Brooks,et al.  Tracer Uptake The Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of , 2013 .

[2]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[3]  T. Yoshiura,et al.  A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[5]  Richard L. Wahl,et al.  FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CT. , 1998, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[6]  Arturo Brunetti,et al.  Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging , 2019, World journal of gastroenterology.

[7]  Peter Smeets,et al.  Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  S. G. Jennings,et al.  Positron-emission tomography and computed tomography of cystic pancreatic masses. , 2007, Clinical radiology.

[9]  A. Rahmim,et al.  Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. , 2019, European journal of radiology.

[10]  Robert J. Gillies,et al.  The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis , 2015, Scientific Reports.

[11]  Vicky Goh,et al.  The effects of segmentation algorithms on the measurement of 18F-FDG PET texture parameters in non-small cell lung cancer , 2017, EJNMMI Research.

[12]  S M Larson,et al.  Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.

[13]  D. Klimstra,et al.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.

[14]  John O. Prior,et al.  Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma , 2017, Oncotarget.

[15]  Laurence E Court,et al.  The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer , 2016, The Journal of Nuclear Medicine.

[16]  Hao Zhang,et al.  Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. , 2012, Academic radiology.

[17]  Dimitris Visvikis,et al.  Characterization of PET/CT images using texture analysis: the past, the present… any future? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Christopher Marshall,et al.  Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer , 2017, European Radiology.

[19]  Jianhua Ma,et al.  Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits , 2018, Theranostics.

[20]  H. Matsubara,et al.  Imaging biomarkers for the treatment of esophageal cancer , 2019, World journal of gastroenterology.

[21]  Stephen S F Yip,et al.  Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction , 2016, Physics in medicine and biology.

[22]  Irène Buvat,et al.  Understanding Changes in Tumor Texture Indices in PET: A Comparison Between Visual Assessment and Index Values in Simulated and Patient Data , 2017, The Journal of Nuclear Medicine.

[23]  S. Parsons,et al.  MAGIC in practice: Experience of peri‐operative ECF/X chemotherapy in gastro‐esophageal adenocarcinomas , 2012, Journal of surgical oncology.

[24]  H. Sakahara,et al.  Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas , 2000, Cancer.

[25]  N. Aide,et al.  Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs) , 2017, EJNMMI Research.

[26]  M. Hatt,et al.  (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. , 2016, The British journal of radiology.

[27]  R. Jeraj,et al.  Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters , 2010, Acta oncologica.

[28]  O. Schillaci,et al.  Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT , 2007, La radiologia medica.

[29]  In-Hwan Kim Current status of adjuvant chemotherapy for gastric cancer , 2019, World journal of gastrointestinal oncology.

[30]  E. Medico,et al.  Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  T. Beyer,et al.  Impact of intensity discretization on textural indices of [18F]FDG-PET tumour heterogeneity in lung cancer patients , 2019, Physics in medicine and biology.

[32]  Robin P Boushey,et al.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. , 2009, Clinics in colon and rectal surgery.

[33]  T. Yoshiura,et al.  Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  J. E. van Timmeren,et al.  Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  E W Steyerberg,et al.  Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.

[36]  T. Naruke,et al.  Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. , 2005, The Annals of thoracic surgery.

[37]  Shan Tan,et al.  Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[38]  Hao Zhang,et al.  Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer , 2013, International Journal of Computer Assisted Radiology and Surgery.

[39]  S. Hyun,et al.  Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  D. Lee,et al.  Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[41]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[42]  Adelin Albert,et al.  FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  M. Soussan,et al.  A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET , 2018, The Journal of Nuclear Medicine.

[44]  S. Kumano,et al.  Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions , 2009, Annals of nuclear medicine.

[45]  Dong Soo Lee,et al.  Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology , 2014, Nuclear Medicine and Molecular Imaging.

[46]  D. Girling Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.

[47]  V. Goh,et al.  Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  C. Van de Wiele,et al.  FDG uptake, a surrogate of tumour hypoxia? , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[49]  D. Townsend,et al.  Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET , 2015, The Journal of Nuclear Medicine.

[50]  D. Nieboer,et al.  Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis. , 2020, Annals of surgery.

[51]  Vicky Goh,et al.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[52]  Hong Soo Kim,et al.  Emerging role of 18F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma , 2019, World journal of gastroenterology.

[53]  P. Marsden,et al.  False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review , 2015, PloS one.

[54]  M. Soussan,et al.  18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer , 2015, PloS one.

[55]  S. Saglam,et al.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  Su Ruan,et al.  Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier , 2017, PloS one.

[57]  M. Hatt,et al.  18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort , 2015, The Journal of Nuclear Medicine.

[58]  Richard Tuli,et al.  Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. , 2017, Journal of gastrointestinal oncology.

[59]  B J Krause,et al.  (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[60]  Barry A Siegel,et al.  Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.